Education
About Us
Working with TipRanks
Follow Us
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
RESEARCH TOOLSreports
Comparison Results
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$25.10
HK$11.75B
12.85
-18.66%
―
Keymed Biosciences, Inc.
HK$46.20
HK$12.99B
―
43.48%
0 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$23.10
HK$13.30B
―
413.33%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$22.50
HK$8.99B
243.77
211.20%
―
Performance Comparison
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
25.10
-6.14
-19.65%
HK:1672
Ascletis Pharma, Inc.
9.06
8.16
906.67%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.40
2.08
62.65%
HK:2162
Keymed Biosciences, Inc.
46.20
13.70
42.15%
HK:2171
CARsgen Therapeutics Holdings Ltd.
23.10
18.60
413.33%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
22.50
15.07
202.83%